Goldman stacks up pharma deals

Goldman Sachs has won its fourth drugs mandate in a month after advising a US company on its sale to Merck, the German pharmaceuticals company.

Goldman is advising Sirna Therapeutics, a US biotechnology company on its $1.1bn (€865m) sale to Merck according to a Sirna spokesman. JP Morgan is Sirna's usual adviser according to Standard & Poor's data provider Capital IQ.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump